[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341579-105":59,"doc-detail-341579-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","potential-application-of-the-myocardial-scintigraphy-agent-123ibmipp-in-colon-cancer-cell-imaging","Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging","","[123I]BMIPP, a myocardial fatty acid metabolism imaging agent, accumulates in cancer cells, yet its accumulation mechanism was unclear. The study compared [123I]BMIPP accumulation with [18F]FDG and found substantially higher uptake for [123I]BMIPP. Uptake was assessed using inhibitors under low-temperature conditions, showing decreased accumulation with SSO (CD36 inhibitor) and lipofermata (FATP inhibitor), and increased accumulation with etomoxir (CPT1 inhibitor), indicating metabolic dependence. In tumor-bearing mice, high accumulation occurred in LS180 tumors and also in normal tissues, with tumor-to-intestine ratios comparable to [18F]FDG.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-application-of-the-myocardial-scintigraphy-agent-123ibmipp-in-colon-cancer-cell-imaging/341579/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-application-of-the-myocardial-scintigraphy-agent-123ibmipp-in-colon-cancer-cell-imaging/341579.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of this study regarding [123I]BMIPP?","Question",{"text":112,"@type":113},"To elucidate how [123I]BMIPP accumulates in cancer cells and to clarify the underlying accumulation mechanism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did [123I]BMIPP accumulation compare with [18F]FDG in cancer cells?",{"text":117,"@type":113},"[123I]BMIPP showed much higher accumulation than [18F]FDG across the tested cancer cell comparisons.",{"name":119,"@type":110,"acceptedAnswer":120},"What inhibitor effects supported the role of CD36 and FATPs in [123I]BMIPP uptake?",{"text":121,"@type":113},"Accumulation decreased in the presence of SSO (CD36 inhibitor) and lipofermata (FATP inhibitor), while changes with etomoxir supported metabolic dependence through CPT1-related processes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341579,1790629598,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nPotential Application of the Myocardial Scintigraphy Agent [123 I]BMIPP in Colon Cancer Cell Imaging  \nKakeru Sato 1,2, Yuka Hirayama 1, Asuka Mizutani 3, Jianwei Yao 1, Jinya Higashino 1, Yuto Kamitaka 1,4, Yuka Muranaka 5, Kana Yamazaki 6, Ryuichi Nishii 7, Masato Kobayashi 3, * and Keiichi Kawai 3,8  \nCitation: Sato, K.; Hirayama, Y.; Mizutani, A.; Yao, J.; Higashino, J.; Kamitaka, Y.; Muranaka, Y.; Yamazaki, K.; Nishii, R.; Kobayashi, M.; et al. Potential Application of the Myocardial Scintigraphy Agent  \n[123I]BMIPP in Colon Cancer Cell Imaging. Int. J. Mol. Sci. 2024, 25, 7747 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25147747  \nAcademic Editor: Gabriella Calviello  \nReceived: 2 June 2024  \nRevised: 10 July 2024  \nAccepted: 12 July 2024  \nPublished: 15 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan; [stkk0323@g.u-fukui.ac.jp](stkk0323@g.u-fukui.ac.jp) (K.S.); [yuka0916@stu.kanazawa-u.ac.jp](yuka0916@stu.kanazawa-u.ac.jp) (Y.H.); [sudayjw@outlook.com](sudayjw@outlook.com) (J.Y.); [hjmr0427@icloud.com](hjmr0427@icloud.com) (J.H.); [yuto.kamitaka419@gmail.com](yuto.kamitaka419@gmail.com) (Y.K.)  \n2 Radiological Center, University of Fukui Hospital, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 910-1193, Japan  \n3 Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan; [mizutani.a@staff.kanazawa-u.ac.jp](mizutani.a@staff.kanazawa-u.ac.jp) (A.M.); [kei@mhs.mp.kanazawa-u.ac.jp](kei@mhs.mp.kanazawa-u.ac.jp) (K.K.)  \n4 Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan  \n5 Department of Radiological Technology, Faculty of Health Science, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; [y.muranaka.vt@juntendo.ac.jp](y.muranaka.vt@juntendo.ac.jp)  \n6 Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan; [yamazaki.kana@qst.go.jp](yamazaki.kana@qst.go.jp)  \n7 Department of Integrated Health Sciences, Graduate School of Medicine, Nagoya University, 1-1-20 Daiko Minami, Higashi-ku, Nagoya 461-8673, Japan; [nishii.ryuichi.g1@f.mail.nagoya-u.ac.jp](nishii.ryuichi.g1@f.mail.nagoya-u.ac.jp)  \n[8](8 Biomedical Imaging Research Center)[ Biomedical Imaging Research Center](8 Biomedical Imaging Research Center), [University of Fukui](University of Fukui), [23-3 Matsuokashimoaizuki](23-3 Matsuokashimoaizuki), [Eiheiji](Eiheiji), Fukui 910-1193, Japan  \n* Correspondence: [kobayasi@mhs.mp.kanazawa-u.ac.jp](kobayasi@mhs.mp.kanazawa-u.ac.jp)  \nAbstract: [123I]β-methyl-p-iodophenyl-pentadecanoic acid ([123I]BMIPP), which is used for nuclear medicine imaging of myocardial fatty acid metabolism, accumulates in cancer cells. However, the mechanism of accumulation remains unknown. Therefore, this study aimed to elucidate the accumulation and accumulation mechanism of [123I]BMIPP in cancer cells. We compared the accumulation of [123I]BMIPP in cancer cells with that of [18F]FDG and found that [123I]BMIPP was a much higher accumulation than [18F]FDG. The accumulation of [123I]BMIPP was evaluated in the presence ofsulfosuccinimidyl oleate (SSO), a CD36 inhibitor, and lipofermata, a fatty acid transport protein (FATP) inhibitor, under low-temperature conditions and in the presence of etomoxir, a carnitinepalmitoyl tra","cbCaipvD2nKI3w5T","https://ap.wps.com/l/cbCaipvD2nKI3w5T","pdf",1482779,14,"English","# Abstract\n## Introduction","[{\"question\":\"What was the goal of this study regarding [123I]BMIPP?\",\"answer\":\"To elucidate how [123I]BMIPP accumulates in cancer cells and to clarify the underlying accumulation mechanism.\"},{\"question\":\"How did [123I]BMIPP accumulation compare with [18F]FDG in cancer cells?\",\"answer\":\"[123I]BMIPP showed much higher accumulation than [18F]FDG across the tested cancer cell comparisons.\"},{\"question\":\"What inhibitor effects supported the role of CD36 and FATPs in [123I]BMIPP uptake?\",\"answer\":\"Accumulation decreased in the presence of SSO (CD36 inhibitor) and lipofermata (FATP inhibitor), while changes with etomoxir supported metabolic dependence through CPT1-related processes.\"}]","Potential Application of the Myocardial Scintigraphy Agent [123I]BMIPP in Colon Cancer Cell Imaging | PDF",1790042651,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20dcf54f432193dc59b1106b1771ebee.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9751478b8182a907f1f83969d0e745a1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e35c2add35b0fd2b9155e0a2c75a7513.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80ffdb9edabd2084b5fd208088c4ea49.webp",980,1385]